Figure 3From: Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro Morphologic changes in T24 cells treated with sunitinib (A: 0 μmol/L; B: 0.3125 μmol/L; C: 0.625 μmol/L; D: 1.25 μmol/L; E: 2.5 μmol/L; F: 5 μmol/L; G: 10 μmol/L). After exposure to different concentrations of sunitinib malate for 24 hours, the cells were stained with DAPI and examined using florescence microscopy (magnification 200 ×).Back to article page